PreludeDx products

BREAST SOS a second opinion service, to verify, modify if needed, and help you better understand your diagnosis.

Predicts radiation benefit. DCISionRT is the only test capable of predicting an individual patient’s benefit from radiation therapy. Using DCISionRT provides you with 10-year Total and Invasive Recurrence Risk after breast conserving surgery as well as surgery with radiation therapy. No other test can do this.